Increasing Rates of Maternal Mortality: How Do Overdose Deaths Contribute?
Between 2018 and 2021, pregnancy-associated overdose mortality rates increased among all women in all age groups, tripling in women between the ages of 35 and 44.
Between 2018 and 2021, pregnancy-associated overdose mortality rates increased among all women in all age groups, tripling in women between the ages of 35 and 44.
In this large cohort study analyzing data from publicly insured Medicaid beneficiaries, the overall risk of malformations was lower with buprenorphine than with methadone.
Childbirth-related PTSD is relatively common; routine screening with a survey of PTSD symptoms may identify women in need of specific PTSD interventions.
In this multicenter cohort, maternal cannabis use documented using urine drug sampling was associated with increased risk of adverse pregnancy outcomes related to placental dysfunction.
More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.
Mandatory warning sign policies were not associated with reduced cannabis use during pregnancy, nor did they shift opinions regarding risk among those using cannabis prior to pregnancy.
At this point, the medical use of cannabis is legal in 37 states and the District of Columbia (D.C.). The recreational use of cannabis has been legalized in 21 states and D.C. The downstream effect [...]
A large cohort study from Canada has observed that cannabis use during pregnancy was associated with increased risk of preterm birth, low birth weight and small-for-gestational age.
Treatment with buprenorphine versus methadone during pregnancy is associated with lower risk of preterm birth, low birth weight, small size for gestational age, and NAS.
Opioid use during pregnancy co-occurs with other variables that are associated with worse outcomes in children, specifically maternal depression and the use of alcohol, tobacco, and other drugs.